CannaTrek Named Among Top Performers for Prescribers
The firm constructing a plant-based medicine facility near Shepparton has been recognised as one of the top-performing Australian companies.
Fastest-growing tech companies
Cannatrek was acknowledged at Deloitte’s annual Technology Fast 50 Australia Awards on Thursday night. The company is currently constructing a facility in Lemnos.
In its 22nd edition, the Deloitte Technology Fast 50 Australia program identifies the 50 fastest-growing tech companies in the nation, requiring a minimum cumulative revenue of $8 million over a three-year span.
Deloitte recognized Cannatrek as one of Australia’s leading technology innovators, placing the company in the sixth position on Deloitte’s Fast 50 Australia Awards for 2022.
Founded in 2017, Cannatrek focuses on the research, cultivation, production, and distribution of plant-based medicine.
Information about studies provided by Cannatrek on this website is for education purposes only. It is not a substitute for professional health advice. Nothing contained in this site, or any external site linked to by Cannatrek, is intended to be used as medical advice and it is not intended to be used to diagnose, treat, cure or prevent any disease, nor should it be used for therapeutic purposes or as a substitute for your own health professional’s advice. Cannatrek does not accept any liability for any injury, loss or damage incurred by use of or reliance on the information provided on this website, or any external site linked to by Cannatrek. Further, Cannatrek accepts no responsibility for material contained in a website that is linked to this site. It is the responsibility of the user to make their own decisions about the accuracy, currency, reliability and correctness of information contained in linked external websites.
Related Reading
-
PrescriberTGA information for healthcare professionals
-
Prescriber
Cannatrek named among top performers
